Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Lazard Asset Management
Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in Sarepta Therapeutics Inc Note 1.250 9/1
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $37M | 39M | 0.93 |
| 2024-12-31 | $44M | 40M | 1.10 |
| 2024-09-30 | $47M | 41M | 1.14 |
| 2024-06-30 | $52M | 40M | 1.29 |
| 2024-03-31 | $47M | 40M | 1.17 |
| 2023-12-31 | $41M | 40M | 1.02 |
| 2023-09-30 | $54M | 48M | 1.12 |
Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1
View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1